Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. ORCL
7. AAPL
8. NVS
9. AZN
10. HOOD

Go back to Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
(NASDAQ: AMLX) Delayed: 33.88 --0 (-0%)
Previous Close $33.88    52 Week High $ 
Open $33.88    52 Week Low $ 
Day High $33.88    P/E N/A 
Day Low $33.88    EPS $ 
Volume 48